In the present study, the expression levels of XIST in glioma tissues and the peritumoral brain edema (PTBE) tissues, the relationship between XIST expression and the clinical features in patients with glioma, and the effects of XIST on glioma cell proliferation and chemoresistance to TMZ were evaluated. The gene discussed is XIST; the disease is glioma.